"Authorized" Generic Deals Are Anti-Consumer, Teva Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Group VP-North America Fletcher suggests such deals are "an evolving question" that warrants Federal Trade Commission review.
You may also be interested in...
"Authorized" Generics Do Not Lessen Impact Of Exclusivity Loss – Schering Exec
"Authorized" generic deals between brand manufacturers and generic companies do little to lessen the impact of losing exclusivity on a prescription drug product, Schering-Plough CEO Fred Hassan said May 19
"Authorized" Generics Do Not Lessen Impact Of Exclusivity Loss – Schering Exec
"Authorized" generic deals between brand manufacturers and generic companies do little to lessen the impact of losing exclusivity on a prescription drug product, Schering-Plough CEO Fred Hassan said May 19
Paraplatin "Authorized" Generic To Be Launched By Teva
Bristol's chemotherapeutic agent is expected to have pediatric exclusivity through mid-October, but Teva's version will come to market in June.